Genetic variants of EGFR have also been shown to influence clinical outcome of many different types of cancer including non-small-cell lung cancer (NSCLC) [12], [13], prostate cancer [14], metastatic colorectal cancer (mCRC) [15], and pancreatic cancer [16]. Here, EGFR is linked to non-small cell lung carcinoma.